Zusammenfassung
Epidemiologische Studien belegen, dass Suchterkrankungen bei Patienten mit anderen psychiatrischen Störungen, vor allem bei Patienten mit Psychosen, gehäuft vorkommen. Diese Komorbidität mit Suchterkrankungen erschwert Verlauf und Behandlung der Patienten. Eine integrative Therapie beider Störungen durch einen Therapeuten oder ein Therapeutenteam ist erforderlich.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Barrowclough C, Haddock G, Tarrier N et al (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 158: 1706–1713
Bennett ME, Bellack AS, Gearon JS (2001) Treating substance abuse in schizophrenia. An initial report. J Subst Abuse Treat 20: 163–175
Cantor-Graae E, Nordstrom LG, McNeil TF (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48: 69–82
Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50: 71–83
Dixon L (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 35Suppl: S 93–100
Drake RE, Mueser KT (2000) Psychosocial approaches to dual diagnosis. Schizophr Bull 26: 105–118
Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ (1997) Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis 185: 298–305
Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR (1998) Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 24: 589–608
Drake RE, Essock SM, Shaner A et al (2001) Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 52: 469–476
Duke PJ, Pantelis C, McPhillips MA, Barnes TR (2001) Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 179: 509–513
Gouzoulis-Mayfrank E (2003) Komorbidität Psychose und Sucht — Von den Grundlagen zur Praxis. Steinkopff, Darmstadt
Gouzoulis-Mayfrank E (2004) Doppeldiagnose Psychose und Sucht — Von den Grundlagen zur Praxis. Nervenarzt 75: 642–650
Gut-Fayand A, Dervaux A, Olie JP, Loo H, Poirier MF, Krebs MO (2001) Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 102: 65–72
Häfner H, Bühler B, Hambrecht M, Löffler W, Maurer K, an der Heiden W (2002) Vorzeitige Auslösung der Schizophrenie durch Substanzmissbrauch und Folgen für den weiteren Verlauf. Nervenheilkunde 21: 198–207
Ho AP, Tsuang JW, Liberman RP, Wang R, Wilkins JN, Eckman TA, Shaner AL (1999) Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. Am J Psychiatry 156: 1765–1770
Hubbard JR, Martin PR (2001) Substance abuse in the mentally and physically disabled: an overview. In: Hubbard JR, Martin PR (Hrsg) Substance abuse in the mentally and physically disabled. Marcel Dekker, New York, S 1–10
Hunt GE, Bergen J, Bashir M (2002) Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 54: 253–264
Lambert M, Haasen C, Mass R, Krausz M (1997) Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten. Psychiatr Prax 24: 185–189
Lammertink M, Lohrer F, Kaiser R, Hambrecht M, Pukrop R (2001) Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse. Acta Psychiatr Scand 104: 361–366
Lee MA, Meltzer HY (2001) Substance abuse in schizophrenia. Biological factors mediating comorbidity and the potential role of atypical antipsychotic drugs. In: Hubbard JR, Martin PR (Hrsg) Substance abuse in the mentally and physically disabled. Marcel Dekker, New York, S 77–101
Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recentonset schizophrenic disorders. Arch Gen Psychiatry 51: 273–279
Löhrer F, Tuchtenhagen FR, Kunert HJ, Hoff P (2002) Zur Rehabilitationsbehandlung von psychotischen Substanzgebrauchern — Epidemiologie, Klinik und Prognose. Prax Klin Verhaltensmed Rehabil 57: 71–78
Minkoff K (1989) An integrated treatment model for dual diagnosis of psychosis and addiction. Hosp Community Psychiatry 40: 1031–1036
Mueser KT, Yarnold PR, Bellack AS (1992) Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand 85:48–55
Mueser KT, Drake RE, Wallach MA (1998) Dual diagnosis: a review of etiological theories. Addict Behav 23: 717–734
Mueser KT, Yarnold PR, Rosenberg SD, Swett C Jr, Miles KM, Hill D (2000) Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull 26: 179–192
Osher FC (1996) A vision for the future: toward a service system responsive to those with co-occurring addictive and mental disorders. Am J Orthopsychiatry 66: 71–76
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511–2518
Soyka M (2000) Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 176: 345–350
Swanson JW, Swartz MS, Essock SM et al (2002) The social-environmental context of violent behavior in persons treated for severe mental illness. Am J Public Health 92:1523–1531
Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB (1996) Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 20: 145–151
Ziedonis DM, Fisher W (1994) Assessment and Treatment of Comorbid Substance Abuse in Individuals with Schizophrenia. Psychiatric Ann 24: 477–483
Ziedonis DM, Trudeau K (1997) Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull 23: 229–238
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Gouzoulis-Mayfrank, E. (2006). Komorbidität Psychose und Sucht — was tun?. In: Schneider, F. (eds) Entwicklungen der Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30100-3_28
Download citation
DOI: https://doi.org/10.1007/3-540-30100-3_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30099-1
Online ISBN: 978-3-540-30100-4
eBook Packages: Medicine (German Language)